Amf Tjanstepension Ab Gilead Sciences, Inc. Transaction History

Amf Tjanstepension Ab

$13.5 Billion
Q3 2024

A detailed history of Amf Tjanstepension Ab transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Amf Tjanstepension Ab holds 400,819 shares of GILD stock, worth $37.7 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

400,819

Previous 400,819 -0.0%

Holding current value

$37.7 Million

Previous $33.6 Million -0.0%

% of portfolio

0.25%

Previous 0.25%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$66.59 - $83.99 $3.42 Million - $4.32 Million	51,390 Added 14.71%	400,819 $33.6 Million
Q1 2024 Apr 16, 2024	SELL	$71.58 - $87.29 $449,522 - $548,181	-6,280 Reduced 1.77%	349,429 $25.6 Million
Q3 2023 Oct 26, 2023	SELL	$73.94 - $80.67 $17.1 Million - $18.7 Million	-231,774 Reduced 39.45%	355,709 $26.7 Million
Q2 2023 Jul 05, 2023	SELL	$76.01 - $86.7 $2.33 Million - $2.66 Million	-30,698 Reduced 4.97%	587,483 $45.3 Million
Q1 2023 Apr 24, 2023	BUY	$77.31 - $88.08 $4.86 Million - $5.53 Million	62,817 Added 11.31%	618,181 $51.3 Million
Q3 2022 Oct 26, 2022	SELL	$59.54 - $68.01 $193,326 - $220,828	-3,247 Reduced 0.58%	555,364 $34.3 Million
Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $9.02 Million - $10.2 Million	-156,246 Reduced 21.86%	558,611 $34.6 Million
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $84,852 - $106,329	1,465 Added 0.21%	714,857 $42.6 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $1.28 Million - $1.45 Million	19,729 Added 2.84%	713,392 $51.9 Million
Q3 2021 Nov 03, 2021	BUY	$67.69 - $73.03 $3.17 Million - $3.42 Million	46,889 Added 7.25%	693,663 $48.5 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $5.95 Million - $6.51 Million	-93,816 Reduced 12.67%	646,774 $44.6 Million
Q1 2021 Apr 28, 2021	SELL	$60.0 - $68.46 $445,440 - $508,247	-7,424 Reduced 0.99%	740,590 $47.9 Million
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $6.59 Million - $7.51 Million	116,334 Added 18.42%	748,014 $43.7 Million
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $5.21 Million - $6.55 Million	-83,921 Reduced 11.73%	631,680 $39.9 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $15.2 Million - $17.7 Million	-210,529 Reduced 22.73%	715,601 $55.1 Million
Q1 2020 Apr 14, 2020	SELL	$62.63 - $80.22 $16.5 Million - $21.2 Million	-263,998 Reduced 22.18%	926,130 $69.2 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $2.53 Million - $2.78 Million	41,029 Added 3.57%	1,190,128 $77.3 Million
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $5.35 Million - $5.91 Million	85,598 Added 8.05%	1,149,099 $72.8 Million
Q2 2019 Jul 11, 2019	BUY	$61.87 - $69.38 $6.25 Million - $7.01 Million	100,976 Added 10.49%	1,063,501 $71.9 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $6.3 Million - $7.06 Million	-100,779 Reduced 9.48%	962,525 $62.6 Million
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $8.76 Million - $11.4 Million	-144,751 Reduced 11.98%	1,063,304 $66.5 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $35,782 - $39,617	502 Added 0.04%	1,208,055 $93.3 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $1.04 Million - $1.21 Million	-16,041 Reduced 1.31%	1,207,553 $85.5 Million
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $2.5 Million - $3.04 Million	-34,288 Reduced 2.73%	1,223,594 $92.2 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $4.55 Million - $5.34 Million	63,927 Added 5.35%	1,257,882 $90.1 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $86.1 Million - $102 Million	1,193,955	1,193,955 $96.7 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amf Tjanstepension Ab, based on Form 13F filings with the SEC.

News

Stay updated on Amf Tjanstepension Ab with notifications on news.

Account

Amf Tjanstepension Ab Gilead Sciences, Inc. Transaction History